Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cascino, G. D.
Right arrow Articles by Sharbrough, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cascino, G. D.
Right arrow Articles by Sharbrough, F. W.
NEUROLOGY 1989;39:1115
© 1989 American Academy of Neurology

Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy

Gregory D. Cascino, MD, Kathryn A. Hirschorn, MD, Clifford R. Jack, MD and Frank W. Sharbrough, MD

Departments of Neurology and Neuroradiology, Mayo Clinic, Rochester, MN.

We performed magnetic resonance imaging (MRI), before and after the administration of gadolinium-DTPA (Gd-DTPA), in 23 patients with medically refractory partial epilepsy who subsequently had surgical treatment for their seizure disorder. In most patients, 61%, unenhanced and enhanced MRI studies were negative. In 26% the unenhanced image was positive, and the abnormality enhanced with Gd-DTPA. In 13% the unenhanced MR image was positive, but the abnormality did not enhance with Gd-DTPA. Gd-DTPA does not appear to increase the diagnostic yield of MRI in the presurgical evaluation of patients with partial epilepsy if the unenhanced MRIs are normal.

Address correspondence and reprint requests to Dr. Cascino, Department of Neurology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.

Presented in part at the forty-first annual meeting of the American Academy of Neurology, Chicago, IL, April 1989.

Received February 24, 1989. Accepted for publication in final form March 13, 1989.




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
E. L. So
Role of Neuroimaging in the Management of Seizure Disorders
Mayo Clin. Proc., November 1, 2002; 77(11): 1251 - 1264.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
W. O. Tatum IV, S. R. Benbadis, and F. L. Vale
The Neurosurgical Treatment of Epilepsy
Arch Fam Med, November 1, 2000; 9(10): 1142 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.